Velcade is now also approved in the EU in combination with pegylated liposomal doxorubicin or dexamethasone for the treatment of adult patients with progressive multiple myeloma who have received at least 1 prior therapy and who have already undergone or are unsuitable for haematopoietic stem cell transplantation (External Source EMA , Johnson & Johnson, FEB 19, 2014, View Source [SID:1234500092]).